CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Open-market sale 10% owner sold 50,000 shares at $4.06 ($203,000)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 4 Open-market buy 10% owner bought 29,899 shares at an average $3.87 ($115,595)
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 8-K/A Event Exhibits
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Acquisition or sale completed · Shareholder vote results
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 85,902 shares at an average $3.92 ($336,812)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 506,197 shares at an average $3.68 ($1,860,961)
- 3 Insider Initial Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
Page 31 of 40 · 798 filings